Align Technology, Inc. (NASDAQ:ALGN) Stock Has Consensus Price Target of $193.08 According to Analysts

Shares of Align Technology, Inc. (NASDAQ:ALGN) have received a consensus rating of “Moderate Buy” from the seventeen ratings firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $193.08.

A number of analysts have recently issued reports on ALGN shares. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a research note on Thursday. Zacks Research downgraded shares of Align Technology from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 15th. Raymond James Financial reiterated a “buy” rating on shares of Align Technology in a report on Monday, October 5th. Wall Street Zen lowered shares of Align Technology from a “buy” rating to a “hold” rating in a report on Saturday, October 24th. Finally, BMO Capital Markets started coverage on shares of Align Technology in a research report on Wednesday, July 8th. They issued an “outperform” rating and a $209.00 price objective for the company.

Hedge Funds Weigh In On Align Technology

A number of institutional investors have recently modified their holdings of the stock. Covestor Ltd boosted its holdings in shares of Align Technology by 43.9% in the third quarter. Covestor Ltd now owns 423 shares of the medical equipment provider’s stock valued at $62,000 after purchasing an additional 129 shares during the period. GRIMES & Co WEALTH MANAGEMENT LLC increased its holdings in Align Technology by 10.5% during the 3rd quarter. GRIMES & Co WEALTH MANAGEMENT LLC now owns 36,696 shares of the medical equipment provider’s stock worth $5,334,000 after purchasing an additional 3,488 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new position in Align Technology during the 3rd quarter worth $2,482,000. ProShare Advisors LLC increased its holdings in Align Technology by 1.9% during the 3rd quarter. ProShare Advisors LLC now owns 10,943 shares of the medical equipment provider’s stock worth $1,591,000 after purchasing an additional 203 shares during the period. Finally, Vise Technologies Inc. bought a new stake in Align Technology during the 3rd quarter valued at $339,000. 88.43% of the stock is owned by hedge funds and other institutional investors.

Align Technology Stock Down 2.5%

Shares of NASDAQ:ALGN opened at $149.89 on Friday. The firm has a fifty day simple moving average of $150.45 and a two-hundred day simple moving average of $168.76. Align Technology has a 52 week low of $130.23 and a 52 week high of $200.43. The stock has a market capitalization of $10.73 billion, a P/E ratio of 21.82, a PEG ratio of 1.65 and a beta of 1.67.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.77 by $0.03. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. During the same quarter in the previous year, the company posted $2.61 EPS. The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. On average, analysts expect that Align Technology will post 9.27 earnings per share for the current year.

Align Technology News Roundup

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Align reported third-quarter adjusted earnings of $2.80 per share and revenue of approximately $1.01 billion, exceeding analyst estimates. Higher clear-aligner shipments and an improvement in North American orthodontist shipments provided support. Align Technology beats Q3 earnings and revenue estimates
• Positive Sentiment: The company’s competitive position appears to be improving, while increased iTero scanner installations could support longer-term digital-dentistry adoption. Align Technology competitive threat eased
• Neutral Sentiment: Align guided to fourth-quarter 2026 revenue of $1.0 billion, essentially matching consensus expectations. The in-line outlook offers limited upside surprise for the stock. Align Technology provides fourth-quarter guidance
• Negative Sentiment: Management lowered its 2026 sales outlook despite the quarterly beat, reinforcing concerns that demand and revenue growth remain sluggish. Analysts also flagged lower scanner revenue, even as iTero installations increased. ALGN Q3 earnings and lowered 2026 sales view
• Negative Sentiment: Jefferies cut its price target to $170 from $185, while Morgan Stanley reduced its target to $175 from $188. The reductions indicate more cautious expectations for growth and valuation. Jefferies reduces Align Technology price target
• Negative Sentiment: A CEO succession and management transition add an element of execution uncertainty while the company works to restore growth. Align Technology CEO succession plan

Align Technology Company Profile

Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.

Align’s products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.

The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.